Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by …
ME Pichichero, JR Casey, AB Francis… - Clinical …, 2006 - journals.sagepub.com
A sixth dose of tetanus, diphtheria, acellular pertussis (Tdap) vaccine in adolescents might
produce a differing reactogenicity and/or immunogenicity response depending on the …
produce a differing reactogenicity and/or immunogenicity response depending on the …
Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children
NNT Minh, K Edelman, Q He, MK Viljanen, H Arvilommi… - Vaccine, 1998 - Elsevier
235 healthy 10–12 years old school children were randomly immunized with either a
booster dose of diphtheria-tetanus-acellular pertussis (dTap) or diphtheria-tetanus (dT) …
booster dose of diphtheria-tetanus-acellular pertussis (dTap) or diphtheria-tetanus (dT) …
Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines
C Christy, ME Pichichero, GF Reed, MD Decker… - …, 1995 - publications.aap.org
Objective. To determine whether gender, race (black or white), or level of parental education
influenced serologic responses or reporting of clinical reactions after immunization with …
influenced serologic responses or reporting of clinical reactions after immunization with …
A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a …
DW Scheifele, SA Halperin, JJ Ochnio… - The Pediatric …, 2005 - journals.lww.com
Background: Large injection site reactions commonly follow booster doses of diphtheria-
tetanus-acellular pertussis (DTaP) vaccines at 4–6 years of age. A vaccine with lower …
tetanus-acellular pertussis (DTaP) vaccines at 4–6 years of age. A vaccine with lower …
Pertussis vaccination: use of acellular pertussis vaccines among infants and young children: recommendations of the Advisory Committee on Immunization Practices …
D Guris, PM Strebel, H Jafari, M Wharton, SC Hadler - 1997 - stacks.cdc.gov
Concerns about the safety of whole-cell pertussis vaccines prompted development of
acellular vaccines that are less likely to provoke adverse events because they contain …
acellular vaccines that are less likely to provoke adverse events because they contain …
Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine
S Lugauer, U Heininger, JD Cherry, K Stehr - European journal of …, 2002 - Springer
The objective of this open study was to monitor the long-term effectiveness of the Lederle-
Takeda diphtheria and tetanus toxoids and acellular pertussis antigen (s)(DTaP) vaccine …
Takeda diphtheria and tetanus toxoids and acellular pertussis antigen (s)(DTaP) vaccine …
New developments with pertussis vaccines
NA Halsey, G Peter - Pediatrics, 1995 - publications.aap.org
Extensive efforts on the part of the National Institutes of Health (NIH), vaccine manufacturers,
and other investigators in the United States and Europe have generated important new …
and other investigators in the United States and Europe have generated important new …
Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents
NNT Minh, Q He, A Ramalho, A Kaufhold… - …, 1999 - publications.aap.org
Objective. To evaluate the immunogenicity and reactogenicity of an acellular pertussis
vaccine (pa) either formulated with diphtheria and tetanus toxoids (dTpa) or administered …
vaccine (pa) either formulated with diphtheria and tetanus toxoids (dTpa) or administered …
Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight …
HJ Schmitt, K Beutel, A Schuind, M Knuf… - The Journal of …, 1997 - Elsevier
Objectives: The primary objective was to assess the nature and incidence of adverse events
after a fourth dose of a tricomponent acellular pertussis-diphtheria-tetanus vaccine given in …
after a fourth dose of a tricomponent acellular pertussis-diphtheria-tetanus vaccine given in …
Extensive swelling after booster doses of acellular pertussis–tetanus–diphtheria vaccines
MB Rennels, MA Deloria, ME Pichichero… - …, 2000 - publications.aap.org
Background. Diphtheria and tetanus toxoid combined with acellular pertussis (DTaP)
vaccines are less reactogenic than diphtheria and tetanus toxoid combined with whole cell …
vaccines are less reactogenic than diphtheria and tetanus toxoid combined with whole cell …